How the ASEAN CSDT Is Used in Bangladesh

1. Key takeaways

No official Bangladeshi document adopts the ASEAN Common Submission Dossier Template (CSDT). The position differs from Vietnam, where the CSDT is mandatory for Class C and Class D devices; in Bangladesh there is no such mandatory requirement. What Bangladesh does have is a four-tier classification that is closely aligned with the ASEAN Medical Device Directive (ASEAN MDD), and that alignment makes it practical to arrange the technical documentation along CSDT lines. The distinction is worth stating precisely: the CSDT is usable as a dossier organisation tool, not as a statutory format.

The confusion is common in Chinese-language secondary sources, which tend to infer acceptance of the template from the alignment of classification logic. Alignment of classes is a statement about how devices are ranked; it says nothing about how a submission is bound or read. DGDA works from its own list of required items, and that list does not follow the CSDT chapter structure.

• Status: the CSDT is not a legal format in Bangladesh, because no DGDA document adopts it.
• Why it still works: the four-class system is aligned with the ASEAN MDD, so CSDT chapters map cleanly onto the technical content.
• Submission reality: the dossier is filed against the DGDA item list, not against CSDT chapters.
• Reuse route: the operative provision is guideline §4.7, which recognises foreign certificates and foreign marketing approvals, not foreign formats.

2. Legal basis

The legal position is best read as two separate questions. One is whether a template is prescribed, and the answer is no: DGDA has published no instrument adopting the CSDT. The other is what evidence a submission must carry, and here the guideline is explicit, with four-class classification, notified body quality system certification, design certification for Class D, mandatory disclosure of existing foreign approvals, and a defined standards base. The table records both layers and marks which entries are quoted provisions and which are practical estimates.

Read together, these entries describe a regime that regulates the evidence rather than the presentation. A submission is judged on whether the required certificates exist and whether the conformity story is complete, not on whether the pages follow an ASEAN numbering scheme.

3. Expert insights

Insight 1: treating the CSDT as a legal format is a directional error. It is easy to move from the premise that Bangladeshi classification follows ASEAN to the conclusion that Bangladeshi submissions follow the CSDT, but the two propositions are not linked. What is aligned is the classification logic, not the dossier format. The DGDA submission list, described in article 21 of this series, comprises nine categories of item, and those categories do not correspond to CSDT chapters: the CSDT is organised around device description, evidence of conformity with essential principles, risk analysis and the like, while the DGDA list is organised around the documents that have to be in the file. Compiling to CSDT structure is acceptable; filing must follow the DGDA list. A dossier that presents nine CSDT chapters where the reviewer expects nine item categories creates work for the reviewer at the very first page.

Insight 2: the real value of the CSDT is write once, use in several markets. For a company running Vietnam, Malaysia, Thailand, Indonesia and Bangladesh at the same time, organising the technical documentation to CSDT chapters allows the substantive chapters to be reused across markets, with only the presentation reworked for each authority. That is a genuine efficiency, and it compounds as the number of markets grows. It is worth being clear that this is an efficiency tool, not a compliance shortcut. The content still has to satisfy each national requirement, and in Bangladesh that means satisfying the guideline’s own provisions on standards, conformity evidence and disclosure of foreign approvals.

Insight 3: §4.7, not the CSDT, is Bangladesh’s dossier reuse clause. What DGDA recognises is not that a dossier was formatted according to an ASEAN template, but that the manufacturer already holds quality system and product certification from a foreign NRA or notified body, and marketing approvals elsewhere. The provision is anchored in reuse of evidence, not reuse of format. Getting this right changes where effort goes: it directs attention to keeping foreign certificates current, complete and consistent with the product being registered, rather than to cosmetic conformity with a template that carries no legal weight in Dhaka.

Insight 4: the two readings can coexist without contradiction. None of this argues against using the CSDT. It argues against expecting the template to do regulatory work it cannot do. A technical file written to CSDT chapters is easier to maintain, easier to audit and easier to hand to a partner in another ASEAN market; the same file, re-indexed to the DGDA list, is what actually gets accepted.

4. Practical recommendations

GRZAN uses a two-layer structure. The technical documentation body is written to CSDT chapters, which keeps it reusable across markets. The submission dossier is then rebuilt and bound against the DGDA nine-item list, which is what the reviewer actually checks. To connect the two layers we place a mapping table at the front of the file, listing each DGDA item against the CSDT chapter or chapters where its content sits, so an official can move from the item list to the relevant page without guessing. We do not recommend submitting a CSDT dossier to Bangladesh unchanged. The missing mapping table raises the reviewer’s cost of navigation, and in a paper-based submission that cost is multiplied across every item.

• Write to CSDT, file to DGDA. Keep one technical body and one submission index, and never let the index drift from the body.
• Put the mapping table first. One page, item by item, with page references.
• Audit foreign certificates before drafting. Under §4.7 the certificates must be current and must cover the exact product and models being registered.
• Confirm the standards base under §7.1. Check whether a pharmacopoeial monograph applies to the product before deciding how to present performance evidence.
• Keep the classification argument explicit. State the class under §4.4 and the reasoning, so the reviewer is not left to infer it.

5. Verification checklist

• □ It is clear that the CSDT is an organisation tool in Bangladesh, not a statutory format
• □ Technical documentation body written to CSDT chapters, where applicable
• □ Submission dossier bound against the DGDA nine-item list
• □ Mapping table between CSDT chapters and DGDA items placed at the front
• □ Foreign NRA and notified body certificates and foreign marketing approvals prepared under §4.7
• □ Applicable standards confirmed under §7.1, including ISO, IEC and pharmacopoeial monographs

Regulatory information verified as of 27 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Bangladesh. Our team prepares dossiers to DGDA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com